Rankings
▼
Calendar
IVVD Q3 2021 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena
IVVD
Invivyd, Inc.
$252M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$60M
Net Income
-$60M
EPS (Diluted)
$-0.98
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$54M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$686M
Total Liabilities
$53M
Stockholders' Equity
$633M
Cash & Equivalents
$478M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$60M
-$48M
-25.8%
Net Income
-$60M
-$48M
-25.8%
← FY 2021
All Quarters
Q4 2021 →